Physician

Anil Singh, MD

According to 2025 Medicare claims, Anil Singh, MD (NPI: 1275847162) practices pulmonary disease in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is LUNG SPECIALIST ASSOCIATES OF TEXAS PLLC (NPI: 1417457938; TIN: 824364262) and primary practice location at 75020-4584. Singh is affiliated with the Methodist Alliance for Patients and Physicians (ACO ID: A1196) and CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,034 traditional Medicare patients, billed 7,261 HCPCS/CPT codes, and received $523,295 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,395 prescription claims across 531 beneficiaries totaling $1,020,333 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,166 claims. Open Payments data shows 98 records totaling $1,902. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $51,030 to $523,295. Similarly, Part D prescription costs have risen steadily, from $2,299 to $1,020,333. For DME billing, reported payments moved sharply higher in recent years, from $9,219 to $292,970.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$262K$523K2017 Medicare payment: $51,030 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $129,435 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $114,408 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $184,332 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $450,654 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $467,241 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $509,211 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $523,295 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017189503$51,030
20184811,407$129,435
20194791,345$114,408
20205011,765$184,332
20216055,544$450,654
20228136,576$467,241
20239567,813$509,211
20241,0347,261$523,295

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$510K$1.0M2015 Drug cost: $2,299 (USD; Tot_Drug_Cst)2016 Drug cost: $4,439 (USD; Tot_Drug_Cst)2017 Drug cost: $11,212 (USD; Tot_Drug_Cst)2018 Drug cost: $32,746 (USD; Tot_Drug_Cst)2019 Drug cost: $74,030 (USD; Tot_Drug_Cst)2020 Drug cost: $59,422 (USD; Tot_Drug_Cst)2021 Drug cost: $228,619 (USD; Tot_Drug_Cst)2022 Drug cost: $508,596 (USD; Tot_Drug_Cst)2023 Drug cost: $962,101 (USD; Tot_Drug_Cst)2024 Drug cost: $1,020,333 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R16$2,299
20161750$4,439
20172485$11,212
201845152$32,746
201948227$74,030
202035136$59,422
2021146602$228,619
20222321,138$508,596
20234071,907$962,101
20245313,395$1,020,333

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$181K$361K2018 Medicare payment: $1,694 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,319 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $26,044 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $69,553 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $145,738 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $196,585 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $361,386 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R34$1,694
2019N/R107$4,319
2020N/R66$26,044
202156404$69,553
20223011,136$145,738
20235552,021$196,585
20249393,166$361,386

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes434595$131
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4751,035$95
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4792,138$90
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes4201,323$60
94060Test to measure expiratory airflow and volume changes before and after medication administration341366$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53218,150$389,449
OfevNintedanib Esylate16480$208,446
Breztri AerosphereBudesonide/Glycopyr/Formoterol2498,190$173,379
Breo ElliptaFluticasone/Vilanterol773,180$40,605
Spiriva RespimatTiotropium Bromide702,280$39,604

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)Y13115$117,220
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY74517$54,119
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramN1161$48,078
E0483High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, eachYN/R33$28,193
A7030Full face mask used with positive airway pressure device, eachN59117$12,587

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.98$1,902GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anil Singh, MD?

Tedicare shows public-source Medicare data for Anil Singh, MD (NPI 1275847162), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anil Singh, MD have ACO affiliation data?

Anil Singh, MD is shown with ACO affiliation data for Methodist Alliance for Patients and Physicians (MSSP, ACO ID A1196) and CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Anil Singh, MD?

Anil Singh, MD is linked to LUNG SPECIALIST ASSOCIATES OF TEXAS PLLC (billing NPI 1417457938) in the available physician profile data.

Does Anil Singh, MD have Open Payments data?

Anil Singh, MD has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.